The 110mcg strength of Asmanex Twisthaler (mometasone furoate inhalation powder, from Schering-Plough), an inhaled corticosteroid, is now available for the maintenance treatment of asthma in patients ...
April 14, 2005 -- The U.S. Food and Drug Administration (FDA) has approved mometasone furoate inhalation powder for the maintenance treatment of asthma as prophylactic therapy in patients aged 12 ...
KENILWORTH, N.J. The Food and Drug Administration has approved Schering-Plough’s asthma inhaler Asmanex twisthaler 110 mcg for the maintenance of asthma as a preventive therapy in patients 4 to 11 ...
KENILWORTH, N.J., Aug. 19 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) announced today that ASMANEX(R) TWISTHALER(R) 110 mcg (mometasone furoate ...
FDA Approves Merck's DULERA(R) (mometasone furoate and formoterol fumarate dihydrate) Inhalation Aerosol for the Treatment of Asthma in Patients 12 Years of Age and Older WHITEHOUSE STATION, N.J., Jun ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results